Defense Award | SPE2DB22D2214 | PRIME VENDOR PHARM BRANCH-PHILADELPHIA

SPE2DB22D2214 - PRIME VENDOR PHARM BRANCH-PHILADELPHIA

Federal Contract Award Search » IDC Award

This IDC contract for Pharmaceuticals > Pharmaceutical Products was awarded in FY2022 on May 4, 2022 to Cencora by DLA Medical Directorate. There have been $49.5M in obligations to date with a ceiling value of $1,000M, showing a 5% burn rate so far on the contract. The contract was not competed under any preference program with 4 offers received. We expect a 3 year duration with ultimate completion date of Dec 30, 2025.

Cencora is a contractor located in PA, doing primarily Pharmaceuticals > Pharmaceutical Products work for Defense. The company receives $2.2B annually in federal awards (as of FY2020). Also, they have shown success winning IDC contracts concentrated mainly on a singular customer focused portfolio.

The Federal Government competes and awards an Indefinite Delivery Contract (IDC) to support requirements where the quantity and time of delivery are unknown. Typically referred to as Indefinite Delivery-Indefinite Quantity (IDIQ) contracts, the Government has the option of awarding a single or multiple award IDIQ. Once awarded, an IDIQ acts as a master agreement between the Federal Government and one or more contractors. On an as-needed basis, Federal buying organizations place orders, commonly referred to as Task Orders against an IDIQ, to purchase goods or services available through the IDIQ.

Read the full report


Contract Number
SPE2DB22D2214
Obligations to Date
$49.5M
Ceiling Value
$1,000M
Award Date
05/04/2022
Contract Type
IDC
Competition Set Aside Type
No set aside used

Buying Agency/Office
Defense»Defense Logistics Agency (DLA)»DLA Troop Support»DLA Medical Directorate


Win More Federal Business

Imagine a world where every report, every insight is tailored specifically to you. Our entire platform is configured around your past performance so that everything is relevant.

Collaboration Stack

All the Right Tools

Business Development & Pipeline Management

We start with the largest federal opportunity database, including forecasts and re-competes, and add layer a suite of pipeline management tools.

Personalized Markets

Our market-centric platform adds context to every pursuit. Every opportunity, every report, tailored specifically to you.

Award Research & Market Intelligence

Find gaps in the market, identify key competitors and teaming partners, evaluate performance, and analyze pathways to new business.

Start Your Free Account Today

Gain Full Access to This Report and...
Contract Opportunities
Pipeline Management
Award Research
Funding Analysis
Partner Identification
Industry and Market Intel
Agency Spending Trends
Competitive Insights

Federal Compass is software designed for today’s federal market.

Explore how the right intel and process can help lead your team to greater success.

Create Free Account

Enjoy instant access to the Federal Compass platform

Task Order History

Task Order No. Contractor Obligations Effective Date
SPE2DB22FS2JS AMERISOURCEBERGEN DRUG CORPORATION $558.00 05/24/2022
SPE2DB22FS2JJ AMERISOURCEBERGEN DRUG CORPORATION $31.3k 05/24/2022
SPE2DB22FS2JU AMERISOURCEBERGEN DRUG CORPORATION $7.6k 05/24/2022
SPE2DB22FS2JM AMERISOURCEBERGEN DRUG CORPORATION $6.7k 05/24/2022
SPE2DB22FS2JQ AMERISOURCEBERGEN DRUG CORPORATION $5.8k 05/24/2022
SPE2DB22FS2JR AMERISOURCEBERGEN DRUG CORPORATION $46.5k 05/24/2022
SPE2DB22FS2JP AMERISOURCEBERGEN DRUG CORPORATION $8.1k 05/24/2022
SPE2DB22FS2JT AMERISOURCEBERGEN DRUG CORPORATION $8.2k 05/24/2022
SPE2DB22FS2JH AMERISOURCEBERGEN DRUG CORPORATION $386.23 05/24/2022
SPE2DB22FS2JG AMERISOURCEBERGEN DRUG CORPORATION $5k 05/24/2022
SPE2DB22FS2JL AMERISOURCEBERGEN DRUG CORPORATION $44.94 05/24/2022
SPE2DB22FS2JV AMERISOURCEBERGEN DRUG CORPORATION $1.8k 05/24/2022
SPE2DB22FS2JN AMERISOURCEBERGEN DRUG CORPORATION $360.62 05/24/2022
SPE2DB22FS2JK AMERISOURCEBERGEN DRUG CORPORATION $696.20 05/24/2022
SPE2DB22FS2KE AMERISOURCEBERGEN DRUG CORPORATION $159.93 05/25/2022
SPE2DB22FS2KD AMERISOURCEBERGEN DRUG CORPORATION $303.42 05/25/2022
SPE2DB22FS2KB AMERISOURCEBERGEN DRUG CORPORATION $12.5k 05/25/2022
SPE2DB22FS2JZ AMERISOURCEBERGEN DRUG CORPORATION $53.04 05/25/2022
SPE2DB22FS2JY AMERISOURCEBERGEN DRUG CORPORATION $459.82 05/25/2022
SPE2DB22FS2KC AMERISOURCEBERGEN DRUG CORPORATION $16.5k 05/25/2022

Contracting Resources